SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern

Signal Transduct Target Ther. 2021 May 22;6(1):203. doi: 10.1038/s41392-021-00623-2.

Ji Yun Noh^#^{1

2}, Hye Won Jeong^#^{2

3}, Eui-Cheol Shin^{4

5}

¹ Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
² Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
³ Division of Infectious Diseases, Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
⁴ Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. ecshin@kaist.ac.kr.
⁵ The Center for Epidemic Preparedness, KAIST, Daejeon, Republic of Korea. ecshin@kaist.ac.kr.

^# Contributed equally.

No abstract available

Publication types